Literature DB >> 12553745

The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.

Renke Maas1, Edzard Schwedhelm, Jennifer Albsmeier, Rainer H Böger.   

Abstract

The incidence of erectile dysfunction increases with diabetes, hypertension, hypercholesterolaemia, cardiovascular disease and renal failure. All these conditions are associated with endothelial dysfunction. This review addresses the pathophysiology of erectile dysfunction with a special focus on new insights into nitric oxide (NO)-mediated pathways, oxidative stress and parallels to endothelial dysfunction. NO appears to be the key mediator promoting endothelium-derived vasodilation and penile erection. The possibility is discussed that elevated plasma concentrations of asymmetrical dimethylarginine (ADMA), an endogenous NO synthase inhibitor, may provide an additional pathomechanism for various forms of erectile dysfunction associated with cardiovascular risk factors and disease. Likewise, the role of endothelium-derived factors mediating NO-independent pathways is evaluated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553745     DOI: 10.1191/1358863x02vm429ra

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  39 in total

1.  Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group.

Authors:  Lisa B Kenney; Laurie E Cohen; Margarett Shnorhavorian; Monika L Metzger; Barbara Lockart; Nobuko Hijiya; Eileen Duffey-Lind; Louis Constine; Daniel Green; Lillian Meacham
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

2.  The penis as a barometer of endothelial health.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2003

Review 3.  [Single base polymorphisms and erectile dysfunction].

Authors:  A Eisenhardt; H Rübben; H Sperling
Journal:  Urologe A       Date:  2008-12       Impact factor: 0.639

4.  Time-course changes of nLDL-induced erectile dysfunction.

Authors:  N Durmus; A Toylu; S Evcim; B C Soner; O Demir; E Kahraman; T Demir; B Irer; S Gidener; N Atabey; A Esen
Journal:  Int J Impot Res       Date:  2017-03-16       Impact factor: 2.896

Review 5.  Sexual function and rehabilitation after radiation therapy for prostate cancer: a review.

Authors:  David-Dan Nguyen; Alejandro Berlin; Andrew G Matthew; Nathan Perlis; Dean S Elterman
Journal:  Int J Impot Res       Date:  2021-01-06       Impact factor: 2.896

6.  Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.

Authors:  Haroldo A Toque; Rita C Tostes; Lin Yao; Zhimin Xu; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  J Sex Med       Date:  2010-11-03       Impact factor: 3.802

7.  Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men.

Authors:  B M Hoffman; A Sherwood; P J Smith; M A Babyak; P M Doraiswamy; A Hinderliter; J A Blumenthal
Journal:  Int J Impot Res       Date:  2009-09-24       Impact factor: 2.896

8.  [Therapy of erectile dysfunction in 2005].

Authors:  H Porst
Journal:  Urologe A       Date:  2003-10       Impact factor: 0.639

9.  The impact of metabolic syndrome on retinal findings in patients with erectile dysfunction.

Authors:  Melih Balcı; Yılmaz Aslan; Berçem Bozarslan; Altuğ Tuncel; Mustafa Kayalı; Ali Atan
Journal:  Turk J Urol       Date:  2013-03

Review 10.  Causes of erectile dysfunction.

Authors:  Jeremy P W Heaton; Michael A Adams
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.